Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets | Valvular Heart Disease | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Suri  RM, Burkhart  HM, Daly  RC,  et al.  Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: establishing the benchmark against which percutaneous interventions should be judged.  J Thorac Cardiovasc Surg. 2011;142(5):970-979.PubMedGoogle ScholarCrossref
2.
Gammie  JS, O’Brien  SM, Griffith  BP, Ferguson  TB, Peterson  ED.  Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation.  Circulation. 2007;115(7):881-887.PubMedGoogle ScholarCrossref
3.
Enriquez-Sarano  M, Avierinos  JF, Messika-Zeitoun  D,  et al.  Quantitative determinants of the outcome of asymptomatic mitral regurgitation.  N Engl J Med. 2005;352(9):875-883.PubMedGoogle ScholarCrossref
4.
Grigioni  F, Tribouilloy  C, Avierinos  JF,  et al; MIDA Investigators.  Outcomes in mitral regurgitation due to flail leaflets: a multicenter European study.  JACC Cardiovasc Imaging. 2008;1(2):133-141.PubMedGoogle ScholarCrossref
5.
Kang  DH, Kim  JH, Rim  JH,  et al.  Comparison of early surgery versus conventional treatment in asymptomatic severe mitral regurgitation.  Circulation. 2009;119(6):797-804.PubMedGoogle ScholarCrossref
6.
Ling  LH, Enriquez-Sarano  M, Seward  JB,  et al.  Early surgery in patients with mitral regurgitation due to flail leaflets: a long-term outcome study.  Circulation. 1997;96(6):1819-1825.PubMedGoogle ScholarCrossref
7.
Enriquez-Sarano  M, Sundt  TM  III.  Early surgery is recommended for mitral regurgitation.  Circulation. 2010;121(6):804-811.PubMedGoogle ScholarCrossref
8.
Gillam  LD, Schwartz  A.  Primum non nocere: the case for watchful waiting in asymptomatic “severe” degenerative mitral regurgitation.  Circulation. 2010;121(6):813-821.PubMedGoogle ScholarCrossref
9.
Rosenhek  R.  Watchful waiting for severe mitral regurgitation.  Semin Thorac Cardiovasc Surg. 2011;23(3):203-208.PubMedGoogle ScholarCrossref
10.
Rosenhek  R, Rader  F, Klaar  U,  et al.  Outcome of watchful waiting in asymptomatic severe mitral regurgitation.  Circulation. 2006;113(18):2238-2244.PubMedGoogle ScholarCrossref
11.
Montant  P, Chenot  F, Robert  A,  et al.  Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach.  J Thorac Cardiovasc Surg. 2009;138(6):1339-1348.PubMedGoogle ScholarCrossref
12.
Bonow  RO, Carabello  BA, Kanu  C,  et al.  ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.  Circulation. 2006;114(5):84-231.PubMedGoogle ScholarCrossref
13.
Vahanian  A, Baumgartner  H, Bax  J,  et al.  Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.  Eur Heart J. 2007;28(2):230-268.PubMedGoogle Scholar
14.
Gillinov  AM, Mihaljevic  T, Blackstone  EH,  et al.  Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop?  Ann Thorac Surg. 2010;90(2):481-488.PubMedGoogle ScholarCrossref
15.
Hlatky  MA, Douglas  PS, Cook  NL,  et al.  Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.  J Am Coll Cardiol. 2012;60(7):569-580.PubMedGoogle ScholarCrossref
16.
Tribouilloy  C, Grigioni  F, Avierinos  JF,  et al; MIDA Investigators.  Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets: a long-term follow-up multicenter study.  J Am Coll Cardiol. 2009;54(21):1961-1968.PubMedGoogle ScholarCrossref
17.
Lloyd-Jones  DM, Larson  MG, Leip  EP,  et al; Framingham Heart Study.  Lifetime risk for developing congestive heart failure.  Circulation. 2002;106(24):3068-3072.PubMedGoogle ScholarCrossref
18.
Agricola  E, Oppizzi  M, De Bonis  M,  et al.  Multiplane transesophageal echocardiography performed according to the guidelines of the American Society of Echocardiography in patients with mitral valve prolapse, flail, and endocarditis.  J Am Soc Echocardiogr. 2003;16(1):61-66.PubMedGoogle ScholarCrossref
19.
R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
20.
Hernán  M, Brumback  B, Robins  J.  Marginal structural models to estimate the joint causal effect of nonrandomized treatments.  J Am Stat Assoc. 2001;96(454):440-448.Google ScholarCrossref
21.
Robins  JM, Hernán  MA, Brumback  B.  Marginal structural models and causal inference in epidemiology.  Epidemiology. 2000;11(5):550-560.PubMedGoogle ScholarCrossref
22.
Concato  J, Peduzzi  P, Huang  GD,  et al.  Comparative effectiveness research: what kind of studies do we need?  J Investig Med. 2010;58(6):764-769.PubMedGoogle Scholar
23.
Tietge  WJ, de Heer  LM, van Hessen  MW,  et al.  Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organic mitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial.  Neth Heart J.2012;20(3):94-101. PubMedGoogle ScholarCrossref
Original Investigation
August 14, 2013

Association Between Early Surgical Intervention vs Watchful Waiting and Outcomes for Mitral Regurgitation Due to Flail Mitral Valve Leaflets

Author Affiliations
  • 1Mayo Clinic College of Medicine, Rochester, Minnesota
  • 2Université Catholique de Louvain, Brussels, Belgium
  • 3University of Bologna, Bologna, Italy
  • 4Inserm, ERI-12, University Hospital, Amiens, France
  • 5Aix-Marseille Université, Marseille, France
  • 6University of Modena, Modena, Italy
  • 7Michigan State University, East Lansing
JAMA. 2013;310(6):609-616. doi:10.1001/jama.2013.8643
Abstract

Importance  The optimal management of severe mitral valve regurgitation in patients without class I triggers (heart failure symptoms or left ventricular dysfunction) remains controversial in part due to the poorly defined long-term consequences of current management strategies. In the absence of clinical trial data, analysis of large multicenter registries is critical.

Objective  To ascertain the comparative effectiveness of initial medical management (nonsurgical observation) vs early mitral valve surgery following the diagnosis of mitral regurgitation due to flail leaflets.

Design, Setting, and Participants  The Mitral Regurgitation International Database (MIDA) registry includes 2097 consecutive patients with flail mitral valve regurgitation (1980-2004) receiving routine cardiac care from 6 tertiary centers (France, Italy, Belgium, and the United States). Mean follow-up was 10.3 years and was 98% complete. Of 1021 patients with mitral regurgitation without the American College of Cardiology (ACC) and the American Heart Association (AHA) guideline class I triggers, 575 patients were initially medically managed and 446 underwent mitral valve surgery within 3 months following detection.

Main Outcomes and Measures  Association between treatment strategy and survival, heart failure, and new-onset atrial fibrillation.

Results  There was no significant difference in early mortality (1.1% for early surgery vs 0.5% for medical management, P=.28) and new-onset heart failure rates (0.9% for early surgery vs 0.9% for medical management, P=.96) between treatment strategies at 3 months. In contrast, long-term survival rates were higher for patients with early surgery (86% vs 69% at 10 years, P < .001), which was confirmed in adjusted models (hazard ratio [HR], 0.55 [95% CI, 0.41-0.72], P < .001), a propensity-matched cohort (32 variables; HR, 0.52 [95% CI, 0.35-0.79], P = .002), and an inverse probability–weighted analysis (HR, 0.66 [95% CI, 0.52-0.83], P < .001), associated with a 5-year reduction in mortality of 52.6% (P < .001). Similar results were observed in relative reduction in mortality following early surgery in the subset with class II triggers (59.3 after 5 years, P = .002). Long-term heart failure risk was also lower with early surgery (7% vs 23% at 10 years, P < .001), which was confirmed in risk-adjusted models (HR, 0.29 [95% CI, 0.19-0.43], P < .001), a propensity-matched cohort (HR, 0.44 [95% CI, 0.26-0.76], P = .003), and in the inverse probability–weighted analysis (HR, 0.51 [95% CI, 0.36-0.72], P < .001). Reduction in late-onset atrial fibrillation was not observed (HR, 0.85 [95% CI, 0.64-1.13], P = .26).

Conclusion and Relevance  Among registry patients with mitral valve regurgitation due to flail mitral leaflets, performance of early mitral surgery compared with initial medical management was associated with greater long-term survival and a lower risk of heart failure, with no difference in new-onset atrial fibrillation.

×